Davidson Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Davidson Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,000	Closed	-$45K	–	220
2016 Q3	$45K	Hold	1,000	–	–	0.01%	133
2016 Q2	$49K	Hold	1,000	–	–	0.01%	131
2016 Q1	$52K	Hold	1,000	–	–	0.01%	162
2015 Q4	$64K	Buy	1,000 +300	+43%	+$18.5K	0.01%	164
2015 Q3	$39K	Hold	700	–	–	0.01%	159
2015 Q2	$41K	Hold	700	–	–	0.01%	163
2015 Q1	$43K	Hold	700	–	–	0.01%	157
2014 Q4	$40K	Hold	700	–	–	0.01%	156
2014 Q3	$37K	Hold	700	–	–	﹤0.01%	176
2014 Q2	$36K	Hold	700	–	–	0.01%	162
2014 Q1	$36K	Buy	+700	New	+$32.4K	0.01%	153
2013 Q3	–	Sell	-1,291	Closed	-$50K	–	171
2013 Q2	$50K	Buy	+1,291	New	+$50.3K	0.01%	156

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Davidson Investment Advisors's TEVA Position: Q4 2016 in Review

Davidson Investment Advisors sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 1,000 shares — an estimated $45K sold.

Davidson Investment Advisors first reported a position in TEVA in Q2 2013 and held it in 12 quarters. The position peaked at $64K in Q4 2015. 737 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

Davidson Investment Advisors reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Davidson Investment Advisors sold 1,000 Teva Pharmaceuticals shares in Q4 2016, an estimated $45K.
Davidson Investment Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 12 quarters.
Davidson Investment Advisors's Teva Pharmaceuticals position peaked at $64K in Q4 2015.
737 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on Davidson Investment Advisors's 13F filing for Q4 2016, filed 15 Feb 2017.